Association of pre-admission statin therapy and the inflammatory response in ST elevation myocardial infarction patients.
Zach RozenbaumDor RavidGilad MargolisShafik KhouryNatalia KaufmanGad KerenAssi MilwidskyYacov ShachamPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2018)
Pre-admission statin therapy is associated with a less robust inflammatory response in STEMI patients, highlighting statin's pathophysiological importance.
Keyphrases
- inflammatory response
- end stage renal disease
- st elevation myocardial infarction
- ejection fraction
- cardiovascular disease
- chronic kidney disease
- newly diagnosed
- emergency department
- percutaneous coronary intervention
- prognostic factors
- peritoneal dialysis
- stem cells
- lipopolysaccharide induced
- bone marrow
- patient reported